---
layout: post
title: "力生制药：双清合剂营业收入占总营收比例较低"
date: 2022-03-09 16:52:01 +0800
categories: cailianshe
tags: 财联社新闻
---
<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002393&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002393_0" data-code="K 002393|0|2" data-code2="K 002393|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></p><!-- EM_StockImg_End --><p>力生制药公告，2021年中央药业生产的双清合剂产品实现的营业收入占中央药业营业总收入的2%，占本公司营业总收入的0.3%。双清合剂营业收入占公司营业总收入比例较低。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203092303173042>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)